Dr. Iris Isufi, MD
Claim this profileYale Cancer Center
Area of expertise
Lymphoma
Iris Isufi, MD has run 3 trials for Lymphoma. Some of their research focus areas include:
MALT Lymphoma
Iris Isufi, MD has run 2 trials for MALT Lymphoma.
Affiliated Hospitals
Yale Cancer Center
Yale University
Clinical Trials Iris Isufi, MD is currently running
GM T Cell Therapy Long-Term Follow-Up
for Cancer
This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T-cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least one infusion of GM T cells will be asked to enroll in this LTFU protocol upon either premature discontinuation from, or completion of the prior parent treatment protocol.
Recruiting
1 award
Phase 2 & 3
Experimental Drug
for Leukemia Post-Stem Cell Transplant
This is a multi-center, non-randomized, concurrent controlled, multi-arm, Phase 1 interventional, open-label, biologic assignment-based umbrella study evaluating the feasibility, safety and preliminary efficacy of an escalating dose regimen of up to 2 doses of TSC-100 and TSC-101 in patients with AML, MDS, or ALL following HCT from a haploidentical donor, MMUD, or MUD
Recruiting
1 award
Phase 1
More about Iris Isufi, MD
Clinical Trial Related
8 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Iris Isufi, MD has experience with
- Autologous Hematopoietic Stem Cell Transplantation
- Ibrutinib
- Carboplatin
- Ifosfamide
- Etoposide
- Nivolumab
Breakdown of trials Iris Isufi, MD has run
Lymphoma
Mantle Cell Lymphoma
Acute Myeloid Leukemia
Central Nervous System Hodgkin Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Iris Isufi, MD specialize in?
Iris Isufi, MD focuses on Lymphoma and MALT Lymphoma. In particular, much of their work with Lymphoma has involved DLBCL patients, or patients who are Stage Indolent B-cell Lymphoma.
Is Iris Isufi, MD currently recruiting for clinical trials?
Yes, Iris Isufi, MD is currently recruiting for 2 clinical trials in New Haven Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Iris Isufi, MD has studied deeply?
Yes, Iris Isufi, MD has studied treatments such as Autologous Hematopoietic Stem Cell Transplantation, Ibrutinib, Carboplatin.
What is the best way to schedule an appointment with Iris Isufi, MD?
Apply for one of the trials that Iris Isufi, MD is conducting.
What is the office address of Iris Isufi, MD?
The office of Iris Isufi, MD is located at: Yale Cancer Center, New Haven, Connecticut 06520 United States. This is the address for their practice at the Yale Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.